- Home
- DLY vs SLP Comparison
DLY vs SLP Comparison
Compare DLY & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLY
- SLP
- Stock Information
- Founded
- DLY 2019
- SLP 1996
- Country
- DLY United States
- SLP United States
- Employees
- DLY N/A
- SLP N/A
- Industry
- DLY Investment Managers
- SLP EDP Services
- Sector
- DLY Finance
- SLP Technology
- Exchange
- DLY Nasdaq
- SLP Nasdaq
- Market Cap
- DLY 703.9M
- SLP 675.9M
- IPO Year
- DLY N/A
- SLP 1997
- Fundamental
- Price
- DLY $15.53
- SLP $31.53
- Analyst Decision
- DLY
- SLP Buy
- Analyst Count
- DLY 0
- SLP 8
- Target Price
- DLY N/A
- SLP $47.83
- AVG Volume (30 Days)
- DLY 215.9K
- SLP 298.2K
- Earning Date
- DLY 01-01-0001
- SLP 07-01-2025
- Dividend Yield
- DLY 8.93%
- SLP 0.19%
- EPS Growth
- DLY N/A
- SLP N/A
- EPS
- DLY N/A
- SLP 0.36
- Revenue
- DLY N/A
- SLP $78,564,000.00
- Revenue This Year
- DLY N/A
- SLP $30.21
- Revenue Next Year
- DLY N/A
- SLP $11.83
- P/E Ratio
- DLY N/A
- SLP $87.03
- Revenue Growth
- DLY N/A
- SLP 21.49
- 52 Week Low
- DLY $13.26
- SLP $23.01
- 52 Week High
- DLY $15.95
- SLP $51.22
- Technical
- Relative Strength Index (RSI)
- DLY 56.81
- SLP 52.01
- Support Level
- DLY $15.40
- SLP $29.31
- Resistance Level
- DLY $15.70
- SLP $31.52
- Average True Range (ATR)
- DLY 0.18
- SLP 1.49
- MACD
- DLY 0.05
- SLP -0.37
- Stochastic Oscillator
- DLY 75.00
- SLP 48.04
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.